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Conclusions;: Them were no slgnlticant natione~ gender differences in 
In.hospital complications, management or outcome. Despite recurrent Is- 
chaemle In up to 44%, only up to 16% were investigated Invaslvely during 
admission which demonstrates a national potential for improvement in the 
management of acuta eorenary disease, 
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~ Dally Life Is©humla In Chronic Stable Angina Is 
Related to PlMelet Activation Induced by Increased 
C~oklne Plasma Lcvcla 
l, Ikonomldla, K Andraotft t, C, Statanadls, C, Pttsavoa, IL Economou, 
P. Toutou~as. P. NIhw~nnop0ul0s f , Ca~lOk~ly Ippocmfion Hoplt~f. Athens, 
G~;  ~mm~r~m/fh Ho-~aifal London, UK 
~¢kro~Jnl/: Cimulaffng maarophsge colony stimulating ta~for (MO~F) causes 
m~(~rephage/monowte activation sit atherosclemtic lesions and thus release 
ol v~so~(~tlva aubMan(;aa, tntedauklna lb tilth) and 6 (IL6), pintatat chemoat. 
traolant~ end ffsaue faster, Our Aim was to. assess the relation Of c~ok~nes to 
a) platelet activation and thr~)mbin genPration in viva and b) to the presence 
of transient myocardial Isch~omln In arable angln~ (~A), 
M~, '  We measured prothmmbln fragments (PF1 +~, areola/I) MCSF, 
ILl b, IL6 (pg/ml) plasma ravels end ~4 h urine secretion el 11-deftydrolhrom- 
boxarm B~ (OHTXB~, ng/mg crestlnlne) in 80 patients with SA and in 21 
h~althy contols by ELISA, Blood samples end urine collections were obtained 
at the end el ~ 48 h Hotter monitoring (HM), Patients ware off aspirin tot 3 
weeks before blood end urine sampling, had englographically documented 
disease end positive exemlse taM, 
Results; PFI.~,, MCSF. and IL6 wore increased in patients with SA com- 
pared to controls (PFI+2:2,26 ¢ 1,8 vs 0,g3 ± 4.5, MCSF: 1076 ± 613 vs 
479 ~ ~S7 IL6:4,2 ± 1.3 vs 2 ± 4,9. p ~, 0,01), Only pAtlants with 3 vessel 
disease had higher ILlb than controls (0,41 ± 0,3 va 0,25 ~t. 0.2, p < 0.05). 
Analysis of variance showed that MCSF end ILlb increased according to the 
number of diseased (1-2-3) vessels (p ~ 4,45). Patients with tschaemia on 
HM (40/60) had higher MCSF end DHTXB2 levels compared to those without 
(MCSF: 1124 ± 651 v~ 528 :~ 417, DHTXB2:4,2 :E 3,2 w 2.3 -I 1.9, p .  
0.05), Higher MCSF I . , :  .z ',~ore related to higher ILlb end DHTXB2 levels 
(r : 0,47 and r = 0,44, p ,: 4,0f), 
Conclusion: Elevated cytoktns and PFt+2 plasma levels in SA are sug- 
gestive of enhanced inflammatory activity and increased thmmbin genera- 
tion, We found for the first time In vlvo, that transient ischeemia dunng dally 
lifo (n patients with SA is related to enhanced cytokine and platolet activity 
and not to increased thrombin generation. 
2:15 
~ ' ~  Local Per lvucular  Basic Flbroblast Growth Factor 
(bFGF) Treatment in Patients With Ischemlc Heart 
Olaeaso 
R.J. Lahore, F.W. Sellke, E.R. Edelman, J.D. Pearlman, M. Simons. Han,ard 
Mechcaf School, BfDMC, Boston, MA, USA 
Background: The completeness of revasculedzation in isehemie heart dis- 
ease is a major determinant of long.term outcome. We have previously 
demonstrated that perivascutar bFGF delivery results in functionally sig- 
nificant angiogenesis in an animal model of chronic myocardial ischemia. 
The purpose of this study is to determine the safety and efficacy of local 
perivasculer bFGF deliven] in patients (pts) undergoing CABG who have an 
undoq~edused but ungraftabla rotatory. 
Methods: 8 pts (5 men, 3 women, age 66 ± 6, EF 47 i 14%) undergoing 
CABG with en ischemic myocardial area supplied by a non-graftable vessel 
had implantation of bFGF-heparin alginate microcapsules in the ep~cardial fat 
surrounding that vessel (5 RCA, 3 LCX). 4 pts received a total dose of 10 pg 
and 4 pts received 100 .g of bFGF, Hemodynamic monitoring was pedormed 
for 5 days after treatment, Laboratory parameters, nuclear pedusi0n scans, 
o~rdlac MRI. and echocardiogr~ms vmre pedormed before and 3 months 
after treatment. 
Results: bFGF was well tolerated. Implantation added 2.8 ± 1,1. rain to 
operative time. Them were no hemodynamic effects (baseline MAP 91 ± 
13 mmHg, 5 day MAP 93 ± 8 mmHg) or significant changes in hematologic 
or chemistry profiles during follow-up, Plasma bFGF levels did not increase 
above baseline (17.4 ± 3.3 pg/ml at baseline, 15.9 ± 1.8 pc/mr at 3 days, 
and 16,0 ~ 1.8 pg/ml at 5 days). Clinical follow-up was available on all pts. 
Two pts had aupadiclal wound infections. No other adverse events were 
noted, All pie ware free from angina. 4 pts had enhanced perfu~ion in the 
gnrevasculadzed myo~ardium by nuclear scans and MRI, 
Conclusion: This preliminary study shows that local podvascuter bFGF- 
haparln alglnata (10-140/,g) treatment is feasible and well tolerated, with no 
shod.term adveme events end no detectable increase in circulating bFGF 
loyola, Fudher studies examining the aMely, efficacy and long-term outcome 
are ongoing, 
2:30 • Repcrfualon Prevents Apoptosls In Hibernating 
Myo©srdlum 
T, Lal, L, Ms, D, Linted, W,-C, Wu, A, O!attdoy~, L Gillam, D, Waters, 
G, l~ongefls. C, Chen, HarbeM Heap#M. H~rfforff. Connecticut. USA 
Prior studies from our laboratory have shown that OngOm9 myocyte death 
through epqptoe~ia ox~um in hibernating myocardium (HM), This study was 
designed to assess whether reperlusion after ? days Of severn ~ry  
atonosis ~ffe~ts ap~pto~is n HM. 
&fofh¢~. Th~ gmul~ of pig~ were studied In group 1 (n =~ 6) a llzred 
LAD stenosis was crested, reducing LAD flow from 0,94 ± Gt I  to 056 t 
0,11 mltmilVg el myooardtum (p ~ 0.0t ). Hegione! wall ttticku,,ing decreased 
from 39 ~ 4% to 14 ~ ~,  (p .~ O.Oll, After maintaining eleno~s fm 7 
days, the animals were saenf~ and the LVs were e~an~ned. In g~roup 
2 (n = 5), identical LAD stenoses were placed, reducing flow to 0.54 008 
mt/mtnlg and walt thickening to 8 ± 5% (both p ~ 0.01), The stenoses 
were released at 7 days to repeduse the HM, and the p=g~ ~ kept 
alive for 4 weeks, In group 3 (n = 4) a sham operation was done w~to~t 
stenosls, In altu TOT-dUT, btot!n nick end-labeling was aploimd lt~ detect DNA 
fragmentation, iodicating myocyte apoptosis and "DNA leddering" on agan~e 
gel atectrephoresiS was used to conlimn the DNA fragmentation. Severity of 
epoptosla was expressed as percent of myoo]te nuclei that were apoplot~ 
Restdts: Apoptotic myocylea were delected by in situ end-labating m 
the hlbemating region in all 6 pigs wtthoul repedusmn and in 2 of .5 p~gs 
with repedusion, Severity of apoptosis was ~47 t- 4.66% in the permanent 
stennsis group and 4.23 ± 0.36% in the group with 4 weeks of m ~  Lo 
• ~ 0,01, Apoptollc myocytes were not found in sham pigs o¢ in o..~e, r non-LAD 
reinforces in groups with stenosea. 
Concluseons: Bevem coronan] stenosts with resting hypopertus~on i - 
duces apoptosis in dysfunctional HM. The =educed apopto¢,ts can be pre- 
vented almost entirety by rephrasing the HM. 
2:45 
~ Preconditioning of  Human Myosardium With 
Bradyklnin During PTCA 
M. Leesar, R. Mathafu, N. Xenopoulos, J. Pruin, M. Stoddard, R. Bolti. UnP.~ 
uf Louisville. Louisville, KY. USA 
Brief isctmmla tandem the myocardium more resistant to subsequent =s- 
chemia (ischemic preconditioning). Animal studies have shown that bra(/ykinm 
(BK) receptors play a cdticat role as mediators of this cardioprotect~,,e effect 
and that pmtreatment with BK preconditions the head in a manner sirnaar to 
ischemic preconditioning. However, nothing is known regaling the role el 
BK in preconditioning human myoca,.'dium. Thus. 30 patients were random. 
ized to receive a 10-rain intracoronary tIC) infusion of saline (controls [C|, n 
= 15) or BK (n = 15)= Ten-rain after the end of infusion, pts underwent PTCA 
(three 2-rain balloon inflations, each separated by 5-min). The ST segment 
shifts on the IC-ECG and sudace 12-lead ECG (S-ECG) were measured at 
the end of each inflation: 
IC-ECG (ram) S-ECG (ram) Chest Pain Score 
C BK C BK C BK 
Inflation 1 23±3 12±2" 16±3 7~.1" '68 ~: 5" 39~5" 
Inflation 2 14±2 t1±2 10:12 711 54+7 37±5 
Inflation 3 13 f 2 11 .t 2 9 ± t 7 ± 1 41 ± 6 36 ~ 5 
X ~: SEM; "P -: o.eSvs, controls 
In the control group, the ST shift decreased dunng the second and third 
inflation compared with the first, indicating ischemic preconditioning. In the 
BK group, the ST segment shift was signilicantly reduced during the first 
inflatio ~ compared w,th contm[s (-48% on IC-ECG), indicating attenuation 
of ischemic injury by BK. Furthermore, them were no appreciable differences 
in ST shifts belween the first, second, and third inflation, indicating that BK 
induced a preconditioning effect during the first inflation comparable to thin 
induced by ischemic preconditioning during the second and third inftmion. 
The severity of chest pain was also markedly decreased by BK during the 
first inflation. 
Conclusions: Pretreatment with BK preconditions human myocardium 
against ischemia in rive. suggesting a pathophysiologic role of BK receptors 
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tn the genesis of Ischemio precono~loning in man, This finding may have 
implications for the m~¢hanism of action of ACE inhibitom in ;scheme heart 
~tsease. 
3:00 
~ RMMIon ~ IN~'fuelon, Met lbo l l lm ind  
Fuect loMI  I~¢overy  Early After e, omee~/  
RlnRIl~llrt i l l l~n In l=atkmte With H lbemol lng  
MIF~.IRIlum 
F, ~ ,  A- Repoaam~, AA, Lotto. F, Borlor~. A, ParolarL E. l~ona, 
L R~.  Mo Pep, R Acetate, P. Blgli~i. O, Proof, ~ept, ot C ~  
Surgeq~ ~ ot ~ Cenao C ~  Fon0azmne I. ~-,~mo 
and CNR ~ ot Cti~cat ~ Secl~n ot Mllan. M~n, 
The ~o~e ol mis st~dy w~ lo ~ea me mcovery ot luect~ and ~ 
retat~a to ~ mye~,d~ blood ,0w (CBF~ and me~0olmm soon after 
~n,LTat~ m p= w~ I~0emalmg myacam~um 15 pm (~4 
~,  I women, mean ~ S~ ± gym) ~ n g  con~ry  a~,y  bypass 
gea l~ (I~ABG| cm !1~ left ~ dee~mding I comn~!y a~ml (LAO) 
LAD lemt0e/was ~ m an I~ ~ ~ e¢ lxx~a~l~y 
and quamMalive ~°tT| msl-te,~,~l~u~ m~a0mg. The LA~BF,  evaluatsd 
by 0nmt ~ veto ( G C ~ ~  0hem~am~ ~ ) ,  tt~ 
by ~ a n ~  echoca~,  were asm~ed ~x~ore and 20-40 
mm attm CABG. I ~  tt.mclion imlmmmd m 74% ol I1~ dysm/nergms 
twaa moron so~e ~ Worn 2.7 ± 0.7 to 1.4 ~ 0.7, p < 0.001). LAD- 
CBF mcnu~ed in aft but o~ pt aNm su~ge~J (frem 56 ± 27 to 121 -,-46 
mL~W~, p < 0.001), k lyocan~ s~bm ~azmn (ca~-xt~ as e~act~ 
and metabo~ flu-,as aooss me I~a.,I) m me LAD temtory was W~cative of 
lactate. 91utamaZe a~d fairy m:~ds uetza l~ a~d sl~j~ aPanme pnxludmn 
bek~e CABG. Mean myecem~ md~za~on ot the numswed s~0stratas ~ 
r~ change after ~ At foSow-up 74% o( I~e dys~- ,~ 
~q~gnuz~rm had fun¢~n omaf~zed or m'q~roved. In ~ m I~bemat- 
mg myocanliurn me a~, -~ metabotism is t~mu~ly  Weserved. des~e 
chn~nicagy reduced CBF a~l ~ .  The CBF impmvemen~ fogowmg 
revascumnzatm~L is assectated with an immediato functmnal ~ m 
mast of ~ secjn~.=~s. ~awng u~changed ~e me~ "u~es. 
3:15 
Tranmlemml Nitroglycerin Therapy Is Not  Ammciated 
With Biochemical  Madlem otl Ox ida lNe Stress 
SO. lt,~lone. CR Pace-~k.  ER. Azevedo, G.E. Newlort. J.D Parker 
or Torero. Canada 
Back q~ur~ Toleranco to organic mtrales may ~ caused by too'eased free 
radecal production. To dale. no hunmn sto~es have examined the m,q~aot f 
ndrale lt'mrapy on biochemcal markers ot ozidatwe swess We e~'kned I1~ 
effect of nilrale therapy on: 1) plasma 8qso-PGF2= (a slable melabolito of 
arachidoeic acid oxidalmn), 2) plasma ~loebyde (MD~ a i~oduct ot 
Iql~d pemxidatmn), and 3) plasma V~amm C (V~t C; wa HPLC) levers. 
Methods. Twemy normal males rece~-~d co,tortuous Iransdermal nmo- 
g~ycenn (TGTN) 0.6 moJhr or no therapy in a randomized, investigator blind. 
parallel destg~n 1 ~  Starting HR. SBP, ~ 8-rso.PGF2, MDA. and 
Vd C levels were measured at basehne. 3 hours ~ acute TGTN and 
after 1 week of sustaJned therapy. 
Therapy was continued and the following day all subiects recewed 2 
grams of oral Vit C or placebo in a double blind, randomized, crossover 
fashion. Belore and 90 n.n after oral Vii C. measures of SBP. HR. and 
plasma Vii C levels were obtained. 
Resutts: Acutely, TGTN caused a significant fall in SBP and an increase 
in HR. Following sustained therapy, Ix~th SBP and HR returned to baseline 
indicating the development of tolerance. 
Baseline A~-ute T~-,I N Sustained TGTN 
8-¢so-PGF2=x (pc~mL) 267 • 84 288 = 111 310 ± 110 
MDA (mmo[/L) 4.7 ± 1.0 4.6 :E 09  4,2 ± 0.7 
V=t C (~*mol/L) 56 ± 22 60 ~: 20 50 ± 25 
Acute and sustained TGTN therapy was not aSsociated with evidence of 
increa:;ed free radical production. The administration of Vit C failed to restore 
the hemodynamic effect o| TGTN (SBP: 119 + 12 vs 118 + 9 mmHg. prevs 
post Vit C) des'~ite a significant increase in plasma Vii C levels (67 ± 48 vs 
112 :~ 39 pmot~L; p < 0.01). 
Conclusion: This studS, cl,=monstrates that a clinically relevant dose of 
TGTN therapy is not associated with biochemical evidence of oxidative 
stress. Consistent with this observation, the acute administration of vita- 
min C does not restore hemodynamic responses to TGTN. This study does 
not suppml I1~ hypothesis that lrcrea~l free ra(~cal ~roduc~,1 is a c-.~t~,e 
of to~erano~ to therapy with TGTN 
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4:00 
i~2:1 l  A , ,~k~ of = ~morphh,m of mo e.=.~,,L., 
. . . . . . . . .  Cormff iu lh~ Nlld¢ OMde I ! ~  O~me WNh 
I~t¢~l la l  ~ In ~ Popu~m 
S. Icmhara, Y. Yamada, I: F~um, M Yoke~a, Nagoya ~ ~ ot 
~ Nagoya, Japan 
Ba~gmun~: Nitr~ re,de (NO) aco~t~z for me t~a l  activ~fy o! e~- 
dethe l l~  re~axing ~,  ~ seem~ It) have an ~ role 
m veso~ and an inh i l~  ol platelel ag~mgation. The impoda~t 
O1 NO I.,dea.s~ in line regulation of h~ul Oe sltreulal~ vascl,llae lone 
oe~ that a~n at3~m~ NO ~ ~ co~l be ~ m a~emnl 
pamok3OmaJ con~uons such as ~ or ~ .  EnOome, 
,a~ ~ ranc oxKle W,tt, me (ecNOS) po~m~oq~srn wM ~i~/  
reported to be associated wire ceronary atom/dl~ease only in cumin1 and 
e~-smokem m Aumral~ We Ittus ~ me asse¢lalton I~wasn V=Lqa- 
Iron in me ecNOS gene a~l the presence ol myecafd~ ~aectt0n (MI) m a 
Japanase ~ ,  
Me#rod- The polymoq~ism in inlxon 4 of 1he ecNOS gene (ecNOS4a~) 
was analyzed in 455 palJee~ v~tt~ MI and 550 cenlrot eub~.  
Resu~: The frequency of me ecNOS,la allele was =gnif¢an~ r~g~er 
m thee M1 palmnts than in controls (odds farm, 1.52, p = 0.007). When g~e 
~nson was ~ to me~ or women, ttm tn~luency of the ecNOS4~ 
allete was ~ higtmr in I11e MI paben~ than in comrels m men (odds 
ratio, 1.52; p = 0.016), but not in t z~n.  In ~e low-fish ~ defim~d 
by a Zx~dy maas~ <27 kg/m z =rid no h i~ of hyponen~ diabetes 
metld-,as, or ~ 1he asz~Oatmn was espe~ly marked 
(odds rabo. 2.50; p = 0.0035). 
Conc/us~n: The polymoephism in i.i,,,~-, 4 of the ecNOS gene may be an 
independent risk factor for MI in fl'm Japanese pOlPulalion. 
4:15 
-2~ Increa~ of Human Cu-Zn Superoxlde Ex~ei ,  lzion 
in a T ~ i c  Momm Model of  
Ischemla#eperfu$1on 
J.R. Tee~;mk. N.Y. Honbo, Y-F.C Lau, JS  Kartiner VA MeoYcsI 
C~r~er.,I./CSF. San F ra~ CA. USA 
Ba~gmur~" ~ human (h-MnSOO) rnanganese-superexioe ~smutase gene 
Is really inducible by ox~ali've and omer slreasas, bul ~ role of me "con- 
~ -  human Cu-Zn SOD in me carffmc response Io ischemm m unclear. 
Our purpose was to assess ~ effect of ischemia/rsperkmon on the e~,~s- 
s~on of h-CuZnSOD in a transgen¢ mouse model (~ft from Dr. Charles J. 
Epstein). 
Meg~ds: Mv;-,e were ra t~ selected from normal CD~I controls, 
h-CuZnSOD lwterozygotes (Htz) and homozygetes (Hmz) at age 6 mont~ 
wt~ a mean .,ma~jht o{ 43 ± 3 grams. Hearts were excmed, pedmed on 
a Langendorff apparalus, and unde~ent 30 m~r~es ot tschemia fogow~l 
by 15 minutes of reperfus~n (IschRep) or perfusion for 45 minulas (Con- 
trot); experiments were perfomled in trtphcale. SOD mRNA mq~resston was 
measured on Northern ~ prepared from total mRNA isolsted from the 
mouse hearts wi~ a h-CuZnSOD probe. Two distinct bands were measured 
by densitometry at approximately 0.7 and 09  kb in Htz and Hmz mlce, the 
values adjusted for 18s intensi~, and added as total CuZn-SOD. 
Resuffs: Baseline SOD expression was increased 5.5-told in Hmz m~"e 
(D = 0.06). No s~nifcant increase in wi/d type mouse SOD during IschRt~o 
(control 0.3 ± 0.2 SO; IschRep 0.4 ± 0.2 units) was noted, although SOD 
transgene express~n markeo]y increased tn boffl Htz (p < 0.01) and Hmz 
(p < 0.05) to 3.0 ± 1.3 and 2.9 ± 0.7 units, respectively, These findings 
suggest minimal activation of the native mouse CuZnSOD in response to 
IschRep. elevated baseline h-CuZnSOD expression in the Hmz mice. and 
marked induction of Iransgene transcription in ~ to IschRep. 
Condus/on: The expression of the constitutively expressed h-CuZn SOD 
gene is incompletely understood; in this transgenic model, it was readily 
inducible. Further study of this increased expression in response to/schRep 
may contffbute to an increased understanding of the mechaniSm of myocar- 
dial salvage in ischemic states. 
w 
E 
~j 
E 
D 
Y 
0 
A 
L 
